NASDAQ:MRVI
Maravai LifeSciences Holdings, Inc. Stock News
$11.10
-0.1000 (-0.89%)
At Close: May 16, 2024
3 Great Growth Stocks Down 20% or More to Buy Now
09:37am, Friday, 27'th Jan 2023
These beaten-down stocks could be poised for major rebounds.
3 Biopharma Stocks That Could Help Make You a Fortune
08:30am, Monday, 16'th Jan 2023
All three are protected by sales of in-demand products, with more on the way.
These Were The Five Best And Worst Performing Mid-Cap Stocks In October 2022
08:22pm, Tuesday, 15'th Nov 2022
Mid-cap companies lie in between the slower growth large-cap stocks and the faster-growth small-cap businesses.
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript
10:56pm, Wednesday, 02'nd Nov 2022
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q3 2022 Results Conference Call November 2, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Interim Chief Exec
This Fallen Growth Stock Is Still a Wall Street Favorite: Here's Why
08:45am, Saturday, 29'th Oct 2022
It's positioned to benefit from the emergence of a new, long-term trend in biopharma.
Maravai LifeSciences: Establishing The Diagnosis
05:36am, Saturday, 22'nd Oct 2022
Maravai has seen a real boom from the pandemic. Sales could likely see pressure in 2023, even as underlying non-pandemic related growth seems solid.
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
04:15pm, Tuesday, 18'th Oct 2022
SAN DIEGO, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q2 2022 Results - Earnings Call Transcript
12:17pm, Sunday, 07'th Aug 2022
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Off
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 Earnings and Revenues Beat Estimates
07:33pm, Thursday, 04'th Aug 2022
Maravai LifeSciences Holdings, Inc. (MRVI) delivered earnings and revenue surprises of 20% and 3.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for th
3 Beaten-Down Stocks That Could Soar in the Second Half of 2022
05:58am, Saturday, 23'rd Jul 2022
Each of these stocks is ready for a rebound.
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 4, 2022
08:00am, Tuesday, 19'th Jul 2022
SAN DIEGO, July 19, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q1 2022 Results - Earnings Call Transcript
08:13pm, Sunday, 08'th May 2022
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Office
Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates
08:18pm, Thursday, 05'th May 2022
Maravai LifeSciences Holdings, Inc. (MRVI) delivered earnings and revenue surprises of 25.58% and 6.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead fo
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022
05:01pm, Thursday, 21'st Apr 2022
SAN DIEGO, April 21, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans
Maravai LifeSciences Announces March 2022 Investor Conference Schedule
04:30pm, Wednesday, 09'th Mar 2022
SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to
